Filing Details

Accession Number:
0001062993-23-012809
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-02 19:08:21
Reporting Period:
2023-06-01
Accepted Time:
2023-06-02 19:08:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1267565 Collegium Pharmaceutical Inc COLL Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1443841 Joseph Ciaffoni C/O Collegium Pharmaceutical, Inc.
100 Technology Center Drive
Stoughton MA 02072
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-01 31,272 $22.09 306,272 No 4 S Direct
Common Stock Disposition 2023-06-02 30,272 $21.58 276,000 No 4 S Direct
Common Stock Disposition 2023-06-02 1,000 $22.25 275,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 27, 2023.
  2. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.81 to $22.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
  3. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.09 to $22.085, inclusive.
  4. The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.09 to $22.39, inclusive.